Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs
Go back to Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs| Bank of Commerce (NASDAQ: ONC) | Delayed: 289.99 +10.10 (3.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $279.89 | 52 Week High | $0.35 | |||
| Open | $283.83 | 52 Week Low | $0.35 | |||
| Day High | $291.75 | P/E | N/A | |||
| Day Low | $283.83 | EPS | $0.00 | |||
| Volume | 315,157 | |||||
| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.96 +0.01 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.95 | 52 Week High | $1.37 | |||
| Open | $0.96 | 52 Week Low | $0.24 | |||
| Day High | $0.98 | P/E | N/A | |||
| Day Low | $0.95 | EPS | $0.00 | |||
| Volume | 925,146 | |||||
